05/10/2024 3:35 PM | Ocuphire Pharma, Inc. (Filer) Ocuphire Pharma (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/10/2024 7:12 AM | Ocuphire Pharma, Inc. (Filer) Ocuphire Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/29/2024 3:43 PM | Ocuphire Pharma, Inc. (Filer) Ocuphire Pharma (Filer)
| Form DEFA14A | |
04/29/2024 3:45 PM | Ocuphire Pharma, Inc. (Filer) Ocuphire Pharma (Filer)
| Form ARS | |
04/19/2024 4:28 PM | Ocuphire Pharma, Inc. (Filer) Ocuphire Pharma (Filer)
| Form PRE 14A | |
04/17/2024 3:23 PM | Ocuphire Pharma, Inc. (Filer) Ocuphire Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/20/2024 3:18 PM | Magrath George (Reporting) Ocuphire Pharma, Inc. (Issuer) Ocuphire Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
03/08/2024 4:20 PM | Ocuphire Pharma, Inc. (Filer) Ocuphire Pharma (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/08/2024 7:21 AM | Ocuphire Pharma, Inc. (Filer) Ocuphire Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/16/2024 3:31 PM | Ocuphire Pharma, Inc. (Filer) Ocuphire Pharma (Filer)
| Form 424B3 | |
02/14/2024 5:32 PM | Jhaveri Nirav S. (Reporting) Ocuphire Pharma, Inc. (Issuer) Ocuphire Pharma (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
02/14/2024 5:35 PM | Jayagopal Ashwath (Reporting) Ocuphire Pharma, Inc. (Issuer) Ocuphire Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 5:37 PM | Jhaveri Nirav S. (Reporting) Ocuphire Pharma, Inc. (Issuer) Ocuphire Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 5:29 PM | Jayagopal Ashwath (Reporting) Ocuphire Pharma, Inc. (Issuer) Ocuphire Pharma (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
01/23/2024 11:15 PM | Ocuphire Pharma, Inc. (Filer) Ocuphire Pharma (Filer)
| Form EFFECT | |
01/22/2024 5:01 PM | Ocuphire Pharma, Inc. (Issuer) Ocuphire Pharma (Issuer) Zaremba Rabourn Amy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/22/2024 5:01 PM | Hoffmann Bernhard (Reporting) Ocuphire Pharma, Inc. (Issuer) Ocuphire Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/11/2024 3:16 PM | Ocuphire Pharma, Inc. (Filer) Ocuphire Pharma (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/10/2024 4:00 PM | Ocuphire Pharma, Inc. (Filer) Ocuphire Pharma (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
01/03/2024 4:57 PM | Benton Susan (Reporting) Ocuphire Pharma, Inc. (Issuer) Ocuphire Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/05/2023 3:30 PM | Ocuphire Pharma, Inc. (Issuer) Ocuphire Pharma (Issuer) Patel Ronil A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/27/2023 5:19 PM | Ocuphire Pharma, Inc. (Issuer) Ocuphire Pharma (Issuer) SCHACHLE JOSEPH K (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
11/27/2023 5:24 PM | Ocuphire Pharma, Inc. (Issuer) Ocuphire Pharma (Issuer) SCHACHLE JOSEPH K (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/27/2023 7:45 AM | Ocuphire Pharma, Inc. (Filer) Ocuphire Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/13/2023 4:42 PM | Ocuphire Pharma, Inc. (Issuer) Ocuphire Pharma (Issuer) Rodgers Richard J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/13/2023 4:46 PM | Ocuphire Pharma, Inc. (Issuer) Ocuphire Pharma (Issuer) Pepose Jay (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/13/2023 7:48 AM | Ocuphire Pharma, Inc. (Filer) Ocuphire Pharma (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/13/2023 7:12 AM | Ocuphire Pharma, Inc. (Filer) Ocuphire Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/03/2023 8:22 AM | Magrath George (Reporting) Ocuphire Pharma, Inc. (Issuer) Ocuphire Pharma (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
11/03/2023 8:29 AM | Magrath George (Reporting) Ocuphire Pharma, Inc. (Issuer) Ocuphire Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/02/2023 7:44 AM | Ocuphire Pharma, Inc. (Filer) Ocuphire Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/01/2023 3:21 PM | Ocuphire Pharma, Inc. (Filer) Ocuphire Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/27/2023 7:45 AM | Ocuphire Pharma, Inc. (Filer) Ocuphire Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/14/2023 7:00 AM | Ocuphire Pharma, Inc. (Filer) Ocuphire Pharma (Filer)
| Form 424B5 | |
08/11/2023 8:27 AM | Ocuphire Pharma, Inc. (Filer) Ocuphire Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/11/2023 7:51 AM | Ocuphire Pharma, Inc. (Filer) Ocuphire Pharma (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/01/2023 10:21 AM | Ocuphire Pharma, Inc. (Filer) Ocuphire Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/14/2023 3:31 PM | Ocuphire Pharma, Inc. (Filer) Ocuphire Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/08/2023 5:48 PM | Gallagher Cam (Reporting) Ocuphire Pharma, Inc. (Issuer) Ocuphire Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/08/2023 5:48 PM | Benton Susan (Reporting) Ocuphire Pharma, Inc. (Issuer) Ocuphire Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/08/2023 5:49 PM | Ocuphire Pharma, Inc. (Issuer) Ocuphire Pharma (Issuer) Pepose Jay (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
Shocking $16T Elon Musk Crypto Leak (Ad) There’s all kinds of “signals” to follow when investing in cryptos.
But there’s one signal you should pay attention to above all others: Venture capital firms.
You want to follow venture capital money into cryptocurrencies before anyone gets word of what’s happening. Click here for all the details… |
06/08/2023 5:49 PM | MANUSO JAMES S J (Reporting) Ocuphire Pharma, Inc. (Issuer) Ocuphire Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/08/2023 5:49 PM | Ainsworth Sean (Reporting) Ocuphire Pharma, Inc. (Issuer) Ocuphire Pharma (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/02/2023 3:30 PM | Ocuphire Pharma, Inc. (Filer) Ocuphire Pharma (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |